Pentoxifylline has favorable preventive effects on experimental chronic pancreatitis model
Background: To investigate the protective efficacy of pentoxifylline through biochemical parameters and histopathological scores in a caerulein- and alcohol-induced experimental model of chronic pancreatitis in rats.Methods: A model of chronic pancreatitis with caerulein and alcohol was created in female rats of the genus Sprague Dawley. Pentoxifylline was administered in doses of 25 mg/kg (low dose) and 50 mg/kg (high dose) as a protective agent. Each group contained 8 animals. The groups were: group 1 (control group); caerulein + alcohol, group 2 (low-dose pentoxifylline group); caerulein + alcohol + pentoxifylline 25 mg/kg, group 3 (high-dose pentoxifylline group); caerulein + alcohol + pentoxifylline 50 mg/kg, group 4 (placebo); caerulein + alcohol + saline, group 5 (sham group); only saline injection.Rats were sacrificed 12 h after the last injection, and TNF-α, TGF-β, MDA, and GPx concentrations were measured in blood samples. The histopathologic examination was conducted by a pathologist who was unaware of the groups.Results: The biochemical results of the treatment groups (group 2 and group 3) were statistically significantly lower compared with the control group (group 1) (p < .05). The difference between the low-dose treatment group (group 2) and high-dose treatment group (group 3) was significant in terms of biochemical parameters (p < .05). The difference between group 2 and the control group was not significant in terms of histopathologic scores (p > .05), whereas the difference between the group 3 and the control group was statistically significant (p < .05).Conclusions: As a result, pentoxifylline, which has anti-inflammatory and antioxidant properties, was shown to have protective efficacy in an experimentally generated model of chronic pancreatitis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
---|---|
Enthalten in: |
Scandinavian journal of gastroenterology - 55(2020), 2 vom: 09. Feb., Seite 236-241 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yildirim, Muhammed [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 15.03.2021 Date Revised 15.03.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/00365521.2020.1712471 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM305413163 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM305413163 | ||
003 | DE-627 | ||
005 | 20231225121129.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/00365521.2020.1712471 |2 doi | |
028 | 5 | 2 | |a pubmed24n1018.xml |
035 | |a (DE-627)NLM305413163 | ||
035 | |a (NLM)31942828 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yildirim, Muhammed |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pentoxifylline has favorable preventive effects on experimental chronic pancreatitis model |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.03.2021 | ||
500 | |a Date Revised 15.03.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: To investigate the protective efficacy of pentoxifylline through biochemical parameters and histopathological scores in a caerulein- and alcohol-induced experimental model of chronic pancreatitis in rats.Methods: A model of chronic pancreatitis with caerulein and alcohol was created in female rats of the genus Sprague Dawley. Pentoxifylline was administered in doses of 25 mg/kg (low dose) and 50 mg/kg (high dose) as a protective agent. Each group contained 8 animals. The groups were: group 1 (control group); caerulein + alcohol, group 2 (low-dose pentoxifylline group); caerulein + alcohol + pentoxifylline 25 mg/kg, group 3 (high-dose pentoxifylline group); caerulein + alcohol + pentoxifylline 50 mg/kg, group 4 (placebo); caerulein + alcohol + saline, group 5 (sham group); only saline injection.Rats were sacrificed 12 h after the last injection, and TNF-α, TGF-β, MDA, and GPx concentrations were measured in blood samples. The histopathologic examination was conducted by a pathologist who was unaware of the groups.Results: The biochemical results of the treatment groups (group 2 and group 3) were statistically significantly lower compared with the control group (group 1) (p < .05). The difference between the low-dose treatment group (group 2) and high-dose treatment group (group 3) was significant in terms of biochemical parameters (p < .05). The difference between group 2 and the control group was not significant in terms of histopathologic scores (p > .05), whereas the difference between the group 3 and the control group was statistically significant (p < .05).Conclusions: As a result, pentoxifylline, which has anti-inflammatory and antioxidant properties, was shown to have protective efficacy in an experimentally generated model of chronic pancreatitis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chronic pancreatitis | |
650 | 4 | |a caerulein | |
650 | 4 | |a ethanol | |
650 | 4 | |a pentoxifylline | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Transforming Growth Factor beta |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a Malondialdehyde |2 NLM | |
650 | 7 | |a 4Y8F71G49Q |2 NLM | |
650 | 7 | |a Ceruletide |2 NLM | |
650 | 7 | |a 888Y08971B |2 NLM | |
650 | 7 | |a Glutathione Peroxidase |2 NLM | |
650 | 7 | |a EC 1.11.1.9 |2 NLM | |
650 | 7 | |a Pentoxifylline |2 NLM | |
650 | 7 | |a SD6QCT3TSU |2 NLM | |
700 | 1 | |a Kaplan, Mustafa |e verfasserin |4 aut | |
700 | 1 | |a Duzenli, Tolga |e verfasserin |4 aut | |
700 | 1 | |a Tanoglu, Alpaslan |e verfasserin |4 aut | |
700 | 1 | |a Kucukodaci, Zafer |e verfasserin |4 aut | |
700 | 1 | |a Onal Tastan, Yesim |e verfasserin |4 aut | |
700 | 1 | |a Cakir Guney, Basak |e verfasserin |4 aut | |
700 | 1 | |a Serindag, Zeliha |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scandinavian journal of gastroenterology |d 1966 |g 55(2020), 2 vom: 09. Feb., Seite 236-241 |w (DE-627)NLM000055166 |x 1502-7708 |7 nnns |
773 | 1 | 8 | |g volume:55 |g year:2020 |g number:2 |g day:09 |g month:02 |g pages:236-241 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/00365521.2020.1712471 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 55 |j 2020 |e 2 |b 09 |c 02 |h 236-241 |